Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 10.718\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a CCC(CC)C(=O)Nc1nnc(SCC(=O)NC(C)(C)C)s1
b CCn1nc([N+](=O)[O-])c2c(-c3nc4ccccc4o3)c(N)n(CCCOC)c2c1=O
Answer: a. CCC(CC)C(=O)Nc1nnc(SCC(=O)NC(C)(C)C)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(CC)C(=O)Nc1nnc(SCC(=O)NC(C)(C)C)s1
CCC(CC)C(=O)Nc1nnc(SCC(=O)NC(C)(C)C)s1
N-[5-[2-(tert-butylamino)-2-oxoethyl]sulfanyl-1,3,4-thiadiazol-2-yl]-2-ethylbutanamide